Spidogale

Quick links to important sections

Spidogale

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Spidogale

Property Description
Active ingredients Benzyl Benzoate, Sulfur
Form Emulsion (Lotion), Cream, or Ointment
Pharmacological class Antiparasitic agent (Scabicide, Pediculicide)
Common use Clearance of skin infestations (mites, lice)
Origin Semi-synthetic and Elemental

Spidogale is a topical fixed-dose combination medicine classified primarily as an antiparasitic agent, designed to manage external skin infestations. Its core identity is defined by the synergistic action of its two distinct active ingredients: Benzyl Benzoate and Sulfur. Spidogale is typically positioned for use across pediatric and adult patient groups and often utilizes the highly spreadable emulsion (lotion) form, a factor differentiating it from more traditional, highly viscous sulfur ointments.


What Type of Medicine is Spidogale? (Identity and Classification)

Spidogale belongs to the specialized pharmacological class of scabicides and pediculicides, targeting the parasites responsible for scabies and pediculosis. The efficacy of this combined formulation against these persistent infestations is documented. The drug is a combination medicine containing the semi-synthetic compound Benzyl Benzoate and the elemental substance Sulfur. This dual-agent approach is a distinguishing feature for providing enhanced action over monotherapies for specific infestations.


What are the Active Ingredients and Forms? (Composition and Physical Nature)

The key active ingredients are Benzyl Benzoate and Sulfur, which are formulated exclusively for topical application directly onto the skin. The medicine is supplied in various dosage forms, including a liquid emulsion, a cream, or an ointment. These forms are engineered to ensure effective delivery and maximum contact of the antiparasitic components with the affected epidermal area.


What is the General Purpose of Spidogale? (Overall Therapeutic Goal)

The general purpose of Spidogale is the eradication of external dermatological parasites. Benzyl Benzoate provides a potent neurotoxic action, neutralizing the organisms, while Sulfur contributes an auxiliary antiparasitic and beneficial keratolytic effect. Benzyl Benzoate is included on the World Health Organization essential medicines list. This means that a core ingredient in Spidogale is recognized as a crucial therapy for eliminating parasitic conditions. This integrated approach ensures the swift clearance of the infestation, offering relief from the itching and discomfort associated with the presence of mites and lice.

Regulatory References

  1. Benzyl Alcohol Topical: MedlinePlus Drug Information
  2. Benzyl benzoate - eEML

What side effects are possible with Spidogale?

Possible Side Effects and Safety Information

Spidogale is a topical combination agent whose officially documented safety profile centers on local skin reactions and regulatory constraints on use. The adverse reactions are categorized based on frequency and the specific organ systems affected, as outlined in government regulatory labeling.

Documented Adverse Reactions and Frequencies

The most commonly noted adverse effects are related to skin irritation, classified by regulatory documents as follows:

Classification Common Reactions
Common Burning sensation at the application site.
Uncommon Itching (pruritus), skin redness (erythema), stinging, and dryness.
Very Rare Systemic allergic reactions, including anaphylaxis.

These effects primarily fall under the Skin and Subcutaneous Tissue Disorders system-organ class. Reactions such as scaling, blistering, and local crusting are also documented, often as symptoms of excessive application.

Serious Reactions and Safety Constraints

The official labeling notes the risk of serious adverse reactions, which are typically associated with excessive topical use or accidental ingestion. These serious events include convulsions (seizures), CNS stimulation, and sudden loss of consciousness. Systemic allergic reactions are also officially listed as a very rare risk.

Safety Restrictions and Vulnerable Populations:

  • Contraindications: The medicine must not be used by individuals with known hypersensitivity to the active ingredients. It is also contraindicated for use on inflamed or broken skin due to the increased risk of systemic absorption.
  • Pediatric Use: Specific safety cautions are required for infants and children under two years of age, owing to the increased potential for marked systemic absorption and related neurological effects.
  • General: Contact with the eyes and mucous membranes must be strictly avoided. The label states that persistent or excessive irritation may require discontinuation.

Overdose and Emergency Response

Overdose and When to Seek Help

This section summarizes the officially documented information regarding Spidogale overdose, based on regulatory labeling and official health authority guidance.


Documented Overdose Manifestations

The overdose profile is defined by the risk of systemic absorption, primarily following accidental oral ingestion or through excessive topical use. Documented manifestations center on Central Nervous System (CNS) toxicity. Symptoms may include CNS stimulation, the onset of convulsions, and potentially severe outcomes such as respiratory paralysis or failure. Excessive topical application is officially reported to cause systemic symptoms and severe local reactions, including skin blistering or scaling. The patient must be managed with appropriate observation.


Emergency Action and Management

Immediate medical attention or contact with a Poison Center is required in the event of suspected accidental ingestion. The management strategy is dictated by regulatory texts, which confirm that no specific antidote is known for the Sulfur component. Treatment is therefore strictly supportive and symptomatic. Officially described interventions for severe poisoning include aspiration and gastric lavage. For the control of convulsions, supportive treatment such as the use of intravenous diazepam is specified as part of the management protocol.

Therapeutic Uses of Spidogale

What Spidogale Treats: Main Uses and Benefits

Spidogale is utilized in the management of acute or recurrent ectoparasitic infestations.

The primary therapeutic use of this topical agent is for the management of ectoparasitic dermatological diseases, which include scabies (mite infestations) and pediculosis (lice infestations). It is generally applied in clinical settings that involve persistent infestations or when additional management support is needed in situations involving certain distressing symptoms. This treatment assists with managing the active infestation by eliminating the organisms and their ova.

The medication is relevant for easing symptoms related to severe pruritus (intense itching) and the resulting skin manifestations. Relief from the parasites contributes to improved patient comfort and assists with maintaining functional stability, especially since these symptoms often worsen at night. As many patients seek treatment primarily for the distressing discomfort, the application focuses on symptomatic assistance.


Quick Fact: Relief for Severe Pruritus This medicine is relevant for easing symptoms related to intense itching and discomfort associated with the parasitic activity, supporting the patient during episodes of heightened symptomatic distress.

Regulatory References

  1. NIH MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

This section outlines the official eligibility requirements for Spidogale as specified in government regulatory documents.

Populations Excluded from Use

Classification Regulatory Statement
Contraindicated Populations Individuals with a known hypersensitivity or allergy to the active ingredient or any excipients.
Age Restriction (Absolute) Infants and young children below the specific minimum age stated on the label (e.g., typically under 2 years of age).
Physiological Status Use is not recommended or a category of risk exists for pregnant and breastfeeding women due to insufficient data or potential for harm.

Conditional Eligibility and Restrictions

Constraint Regulatory Statement
Conditional Use (Children) Use in older children is only permitted under conditional eligibility, requiring the product to be mixed with water in a specific dilution ratio prior to application.
Condition-Specific Rules The medicine should not be used on broken or acutely inflamed skin, as this may increase absorption or worsen the underlying condition.
Older Adults Safety and efficacy may not be specifically established as being the same as in younger adults, and caution is noted for dry skin conditions.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile for Spidogale, a topical combination containing Benzyl Benzoate and Sulfur, primarily involves localized incompatibility and physical interference with other products applied to the skin. Regulatory information focuses on preventing localized adverse reactions and maintaining the drug's effectiveness, rather than systemic drug-drug interactions.


Documented Topical and Physical Interactions

Interaction Type Interacting Substance/Condition Regulatory Caution
Chemical Incompatibility Topical mercury-containing preparations Contraindicated due to risk of severe localized irritation and black skin staining.
Pharmacodynamic Risk Other topical antiparasitics or insecticides Use with caution, as combination may influence overall safety and effectiveness.
Physical Interference Oil-based preparations (creams, lotions, oils) Requires washing/drying of hair/scalp prior to application to ensure proper contact and action.
Exposure Risk Broken or inflamed skin Application restricted; the condition increases systemic absorption and potential for side effects.

Other Considerations

There are no documented warnings in regulatory prescribing information concerning systemic metabolic (CYP-mediated) or transporter-based interactions for the topical use of Spidogale's active ingredients. Similarly, no specific food, alcohol, or herbal product interactions are officially specified. The primary focus remains on avoiding chemical reactions and ensuring the integrity of the application site.

Mechanism of Action

How Spidogale Works: Mechanism of Action

Spidogale operates through a dual-mechanism strategy combining rapid neural toxicity with sustained metabolic disruption and physical enhancement, resulting in a combined biological effect on the target organisms.


Disrupting the Parasite's Nervous System

The ingredient Benzyl Benzoate initiates the core mechanism by acting as a neurotoxin. It targets the arthropod nervous system, causing a direct and non-specific interference with nerve impulse transmission. This molecular mechanism rapidly leads to the functional paralysis and subsequent mortality of the parasite, representing the swift onset of functional disruption.


Metabolic Poisoning and Cellular Shutdown

The mechanism of Sulfur involves its conversion into active sulfide metabolites on the skin. These metabolites function as metabolic poisons, disrupting crucial internal processes by inhibiting enzymes required for cellular respiration and mitochondrial function within the parasite. This cascading effect results in the complete cessation of the parasite's life-sustaining energy production and supports sustained cytotoxicity.


Keratolytic Synergy and Penetration Enhancement

This key domain is driven by the secondary, keratolytic activity of Sulfur's metabolites. These compounds act as reducing agents that chemically modify the disulfide bonds in the skin's keratin layer. This physical mechanism aids in the debridement of the infested epidermal tissue, critically enhancing the penetration and efficacy of both Benzyl Benzoate and the Sulfur metabolites to reach the organisms embedded deep within the epidermal burrows.

Dosage and Administration Information

Spidogale is a topical combination agent administered via the cutaneous route for managing parasitic skin infestations. The labeled instructions define a short-course, intermittent regimen that varies based on the specific infestation being addressed.

For a scabies infestation, the standard regimen involves a thorough application over the entire body surface, starting from the neck down to the soles of the feet. The medicine is typically applied on two consecutive nights, and the preparation is left in place for 8 to 12 hours overnight before being washed off. A second treatment course is sometimes utilized and repeated 7 days later to manage any parasites that may have hatched after the initial course.

For pediculosis (lice), the medicine is applied to the affected area and remains on for a contact time of up to 24 hours before being thoroughly washed.

Usage in pediatric patients involves a specific modification to the application. The full-strength preparation is diluted with water before use, with the dilution ratio varying for older children versus infants. Liquid forms are shaken prior to administration or mixing. Regardless of the indication, thorough bathing and a complete changing of clothing and bedding follow the completion of each treatment course.

Recent Clinical Evidence

Research Evidence: Spidogale

Overview of Studies

Research has evaluated the effect of Spidogale (Benzyl Benzoate) on symptoms associated with parasitic infestations, such as scabies and pediculosis. The research included data from several randomized controlled trials (RCTs) and observational studies, focusing on the resolution of skin lesions and the reduction of itching (pruritus). Studies explored the potential for an effect on symptoms over time.

Efficacy Findings

Clinical studies have compared Spidogale with other common anti-parasitic treatments. Results regarding comparative effectiveness have been varied, suggesting that the clinical cure rate for Spidogale may be comparable to treatments like oral ivermectin in pooled analyses of multiple RCTs.

  • One meta-analysis evaluating topical Spidogale versus oral ivermectin found no significant difference in overall cure rates after two to four weeks of follow-up.
  • Other comparative studies, particularly those against topical permethrin, have explored whether the latter was associated with a change in the observed time frame for clinical improvement during the first week of treatment; however, no significant difference was noted in later follow-up assessments.

Safety and Tolerability

The analysis of study data noted tolerability in the study population. The most commonly reported adverse events in clinical trials of topical Spidogale are related to the application site. These include reports of a burning sensation, local skin irritation, and stinging at the site of application. Research comparing Spidogale with alternative treatments, such as oral ivermectin, often suggests a difference in the incidence of these local side effects.

Frequently Asked Questions (FAQ)

Common questions about Spidogale (FAQ)


Q: How quickly can one expect to see the effects of Spidogale?

One of Spidogale’s active ingredients, Benzyl Benzoate, is described as a neurotoxin that works by rapidly causing functional paralysis of the target parasite. While the mechanism of action is rapid, clinical studies that measure the overall clearance of the infestation typically evaluate the final outcome over a follow-up period of two to four weeks.


Q: What's the difference between Spidogale and similar medicines (Drug X)?

Spidogale is primarily identified by its composition: it is a topical fixed-dose combination medicine that contains both Benzyl Benzoate and Sulfur. This dual-agent composition is a distinguishing feature compared to products that may contain only a single active ingredient.


Q: Is it common to feel tired when taking Spidogale?

The officially documented side effects of Spidogale focus primarily on localized skin reactions at the application site, such as burning, stinging, and irritation. General body effects like feeling tired or fatigued are not specifically listed among the common or uncommon adverse reactions in regulatory safety information.


Q: Can Spidogale be taken with common pain relievers?

Regulatory information focuses on avoiding chemical or physical interference with other topical products. Prescribing information does not list documented warnings regarding systemic interactions with common orally administered pain relievers. The focus of documented interactions is primarily on localized topical agents.


Q: Does Spidogale interact with grapefruit juice or other foods?

Regulatory prescribing information does not specify any official interactions with food, alcohol, or herbal products for the topical use of Spidogale's active ingredients.


Q: Can a person stop using Spidogale suddenly?

Official instructions define Spidogale as a specific, short-course, intermittent regimen. The full treatment course outlined in the regulatory instructions is defined to ensure the complete clearance of the infestation, especially given the need for a second application seven days later in some cases.


Q: Does Spidogale cause weight gain or weight loss?

The documented adverse reactions for Spidogale primarily involve localized skin reactions and serious central nervous system (CNS) effects linked to excessive exposure. Changes in body weight, such as weight gain or weight loss, are not specifically listed among the common or uncommon documented side effects in the official regulatory safety information.


Q: Is there a generic version of Spidogale available?

Spidogale is a combination product. Its core ingredient, Benzyl Benzoate, is recognized by the World Health Organization as an essential medicine and is widely available globally under various generic names in different jurisdictions.


Q: What does official regulatory information say about the risk of dependence with Spidogale?

Regulatory safety information for this topical medicine focuses on the risks associated with high systemic absorption, such as CNS stimulation and seizures. The potential for drug dependence is not listed as a documented risk in the regulatory safety profile.


Q: Can Spidogale affect sleep patterns?

The official label notes a risk of serious reactions, including central nervous system (CNS) stimulation, especially with excessive use or accidental ingestion. While specific sleep disturbances like insomnia are not commonly listed, the treatment course is designed to be applied overnight for a set duration.


Q: What is the longest duration of use examined in clinical studies of Spidogale?

The prescribed regimen for Spidogale involves short, intermittent applications over a period that typically lasts seven to fourteen days, followed by clinical assessment. Extended or continuous long-term use beyond this regulated course is not addressed in the research summaries.


Q: Is it safe to drink alcohol while taking Spidogale?

Regulatory prescribing information does not specify any official interactions with alcohol, food, or herbal products for the topical use of Spidogale's active ingredients.


Q: Does Spidogale affect fertility?

Official regulatory documents indicate that data regarding the effects of the active ingredients in Spidogale on female or male fertility are either limited or unavailable.


Q: Is there a particular time of day Spidogale is usually taken?

The labeled instructions for use in treating scabies specifically state that the preparation must be left in place for 8 to 12 hours overnight before being washed off.


Q: Does Spidogale change the effect of birth control pills?

The primary focus of documented warnings is on localized topical interactions. Regulatory information does not contain documented warnings concerning systemic interactions that would typically affect oral medicines like birth control pills.


Q: Are there any mental health side effects associated with Spidogale?

The official label lists serious adverse events associated with excessive systemic absorption, including Central Nervous System (CNS) stimulation. Effects such as specific mood changes or other mental health side effects are not listed among the commonly documented adverse reactions.


Q: Does Spidogale require special monitoring or tests?

The regulatory focus is on proper local application and avoiding excessive absorption. Standard instructions for the prescribed short course of treatment do not mention the need for routine blood work, liver function tests, or other specific internal monitoring tests.


Q: Is the effectiveness of Spidogale affected by diet?

Regulatory prescribing information does not specify any official interactions with food, alcohol, or herbal products that would affect the topical use of Spidogale's active ingredients.


Q: Is Spidogale approved in countries outside of the United States?

The core ingredient Benzyl Benzoate is included on the World Health Organization’s list of essential medicines. The regulatory documentation used to describe the product indicates that it is authorized in specific countries outside of the US.


Q: Do studies suggest Spidogale works better for some people than others?

Research reviews have shown comparable overall cure rates between Spidogale and certain other treatments. The core evidence does not include specific data to suggest the product works better or worse for different demographic sub-groups, such as by age or weight.


Q: Is there a link between Spidogale and liver function changes?

Documented serious adverse reactions primarily involve the skin and the central nervous system (CNS). Liver function changes are not listed among the common or serious adverse effects associated with the prescribed topical use.


Q: Does taking Spidogale affect driving or operating machinery?

Official documentation implies caution: patients experiencing serious central nervous system (CNS) adverse effects—such as seizures or sudden loss of consciousness, which are listed as very rare risks with excessive exposure—may have their ability to drive or operate machinery impaired.


Q: Is Spidogale intended to cure a condition or manage symptoms?

The general therapeutic goal of Spidogale, as defined in regulatory and authoritative texts, is the eradication and clearance of external dermatological parasites. The general purpose is described in official texts as the eradication and clearance of the parasites.

How should Spidogale be stored and disposed of?

Official Storage and Disposal Instructions

Storage and disposal requirements for Spidogale are mandated by regulatory labeling to ensure product stability and environmental safety.

Storage Requirement Official Condition
Temperature Store at room temperature (20 C to 25 C).
Handling Do not freeze and protect from excessive heat.
Protection Keep in the original, tightly closed container and protect from direct light and moisture.
Safety Keep out of the sight and reach of children.

The official instructions prohibit the disposal of unused or expired Spidogale through household wastewater or drains, as the active ingredients are classified as toxic to aquatic life. The medicine must be disposed of according to local regulations or returned to an approved waste disposal plant.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Spidogale found in:

A-Z Index: